Innovative Plant-Based Medicines Jaguar Health specializes in developing sustainable, plant-derived prescription medicines for gastrointestinal and mental health conditions, presenting opportunities to expand partnerships with integrative healthcare providers and natural product distributors.

Growing Animal Health Portfolio The recent launch of Neonorm Dog and focus on companion animal treatments create potential sales avenues with veterinary clinics, pet health product retailers, and animal care organizations seeking innovative therapeutics.

Strategic International Expansion Jaguar's majority stake in Napo Therapeutics and active efforts to expand crofelemer access in Europe suggest opportunities to collaborate with international distributors and healthcare institutions looking for novel gastrointestinal solutions.

Event Engagement and Visibility Participation in industry conferences and presentation of clinical data position Jaguar as a thought leader, opening doors to partnership discussions with research institutions, healthcare organizations, and government agencies involved in gastroenterology and pediatric health.

Funding and Market Potential With ongoing development efforts and a recent funding round, Jaguar's pipeline presents opportunities for investors and distribution partners interested in the growing natural and biotech drug markets for both human and veterinary applications.